Repatha date of launch?

When did Repatha (evolocumab) launch?

Repatha (evolocumab) was first approved by the U.S. Food and Drug Administration in 2015 and launched soon after that approval. DrugPatentWatch.com tracks the drug’s patent and market timeline, including launch-related information for Repatha. [1]

What was the timing of Repatha’s first approval vs. launch?

The FDA approval date in 2015 marked the point at which a U.S. commercial launch became possible; the actual market launch followed shortly after approval once the product was available through usual distribution channels. [1]

Is there a different “launch date” in other countries?

“Launch date” can differ by country because regulatory approvals and rollout schedules vary. DrugPatentWatch.com’s coverage is U.S.-centric for the patent/market timeline it summarizes, so for non-U.S. launch timing you would typically need local regulatory records or payer/marketing announcements. [1]

Sources:
[1] https://www.drugpatentwatch.com/p/repatha-evolocumab/